Home-based cardiac telerehabilitation for adults with chronic heart failure
Official title: Evaluation of the Effectiveness of a Cardiac Telerehabilitation Program in Chronic Heart Failure
Run by University of Salerno · NCT07023536 · Data updated 2026-11-12
This program will test whether a home-based telerehabilitation course using wearable sensors and remote supervision helps adults with chronic heart failure improve their exercise capacity compared with standard in-hospital rehabilitation.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 205 (estimated) |
| Sponsor | University of Salerno Academic / other |
| Locations | 1 site (Salerno) |
| Status | Recruiting |
| Started | June 10, 2025 |
| Main results expected | July 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | March 11, 2026 |
| Trial ID | NCT07023536 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (≥18) with chronic heart failure of at least six months' duration, NYHA class I–III, on stable medical therapy, able to perform exercise testing, and with sufficient digital literacy or caregiver support.
✕Probably not a fit
Patients with NYHA class IV heart failure, severe comorbidities limiting life expectancy, advanced renal failure (eGFR <30 ml/min/1.73 m²) or on dialysis, pregnancy, or those unable to use the required technology are unlikely to benefit from the home-based program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, single-center observational study compares adults with chronic heart failure who choose a home-based telerehabilitation program to those who opt for standard in-hospital cardiac rehabilitation. Both groups follow the same 8-week individualized aerobic exercise protocol guided by baseline cardiopulmonary exercise testing (CPET). The telerehabilitation arm uses a certified telehealth platform with real-time videoconferencing and medical-grade wearables to monitor ECG, heart rate, blood pressure and SpO2 during sessions. Participants undergo assessments at baseline and at 4, 8, 16, and 24 weeks to measure VO2max, cardiac function, exercise tolerance, biomarkers, and quality of life.
Why it matters
Potential benefit: If successful, this approach could let more patients safely improve fitness and quality of life from home while reducing the need for frequent hospital visits.
How similar studies have gone: Prior randomized and observational studies of cardiac telerehabilitation have often shown comparable improvements in exercise capacity and quality of life to center-based programs, although results vary by patient selection and technology used.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Diagnosis of chronic heart failure for at least 6 months, with stable optimal medical therapy for at least 1 month * New York Heart Association (NYHA) functional class I, II, or III * Hospitalization or outpatient visit requiring intravenous therapy (diuretics, vasodilators, or inotropes) within the past 12 months * Ability to provide informed consent or presence of a legal representative * Digital literacy of the patient and/or caregiver Exclusion Criteria: * Age \< 18 years * Pregnancy * NYHA class IV heart failure * Severe renal insufficiency (eGFR \<30 ml/min/1.73 m²) or on dialysis * Other serious illnesses significantly limiting life expectancy (e.g., end-stage cancer, advanced pulmonary disease)
Where it's running
-
Hospital University San Giovanni di Dio e Ruggi d'Aragona
Salerno, Italy Recruiting
Study contacts
- Study coordinator: Alessia Bramanti, Electronic Engineering
- Email: abramanti@unisa.it
- Phone: +393483809181
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.